openPR Logo
Press release

Bronchiectasis Drugs Market Future Outlook, COVID-19 Impact Analysis, Forecast - 2031

11-14-2024 03:13 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Orion Market Research

Bronchiectasis Drugs Market

Bronchiectasis Drugs Market

The global bronchiectasis drugs market is anticipated to grow at a significant CAGR during the forecast period (2024-2031). Some pivotal factors that are driving the market growth include the high presence of bronchiectasis among the public and the improved infrastructure facilities in the healthcare and medical sector. Another key factor anticipate to drive the market growth include the constant R&D in the field of bronchiectasis drugs coupled with the rising competition among established drug makers.

Get Free Sample link @ https://www.omrglobal.com/request-sample/bronchiectasis-drugs-market

Under the global bronchiectasis drugs market, the major types of drugs available include antibiotics and expectorants. Among these two, antibiotics have the greater demand and are anticipated to continue to stay ahead of the expectorant segment in the future years. An increase in the number of respiratory diseases has been driving the antibiotics demand. In addition, the low cost and easy availability of these antibiotics have led to the demand substantially as well.

Some key players operating in the market include Endo International Plc, GlaxoSmithKline Plc,., Reckitt and Benckiser Group Plc, among others. These players are eyeing to strengthen their position in the market by adopting various strategies as mergers and acquisitions, partnerships, collaborations, new product launch and development in the existing product portfolio, and so on. For instance, in April 2014, Bayer HealthCare announced that the US Food and Drug Administration's (FDA) Office of Orphan Products Development has granted orphan drug designation for its investigational Ciprofloxacin Dry Powder for Inhalation (Ciprofloxacin DPI) for the treatment of non-cystic fibrosis bronchiectasis (NCFB). Such approvals for the novel forms of drugs from the FDA for the treatment of bronchiectasis are further anticipated to drive the market growth during the forecast period.

Full report of Bronchiectasis Drugs Market available @ https://www.omrglobal.com/industry-reports/bronchiectasis-drugs-market

Market Coverage

Segment Covered
Regions Covered- Globally

Competitive Landscape: Endo International Plc, GlaxoSmithKline Plc,., Reckitt and Benckiser Group Plc, among others.

Key questions addressed by the report

What is the market growth rate?
Which segment and region dominates the market in base year?
Which segment and region will project fastest growth in the market?
How COVID-19 impacted the market?
o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

Who is the leader in the market?
How players are addressing challenges to sustain growth?
Where is the investment opportunity?

Global Bronchiectasis Drugs Market by Segmentation

By Product

Antibiotics
Expectorants
Other Drugs

Reasons to Buying From us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.



For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/bronchiectasis-drugs-market

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bronchiectasis Drugs Market Future Outlook, COVID-19 Impact Analysis, Forecast - 2031 here

News-ID: 3736292 • Views:

More Releases from Orion Market Research

Passenger Cars MRO Market Size Trends and Forecast by Application, Type, and Geography, Opportunity Analysis
Passenger Cars MRO Market Size Trends and Forecast by Application, Type, and Geo …
The global passenger cars Maintenance, Repair, and Overhaul (MRO) market was valued at approximately $96.35 billion in 2024 and is projected to reach around $125.06 billion by 2034, growing at a compound annual growth rate (CAGR) of 2.64% during the forecast period. Passenger Cars MRO Market Overview The passenger cars MRO market is experiencing steady growth, driven by the increasing average age of vehicles on the road, necessitating regular maintenance
Digital Manifold Gauges Market Estimated to Experience a Hike in Growth by 2030
Digital Manifold Gauges Market Estimated to Experience a Hike in Growth by 2030
The global digital manifold gauges market was valued at approximately $596.17 million in 2022 and is projected to reach around $790.55 million by 2030, growing at a compound annual growth rate (CAGR) of 3.73% from 2024 to 2030. Digital Manifold Gauges Market Overview The digital manifold gauges market is experiencing steady growth, driven by the increasing demand for accurate and efficient refrigerant management across various industries, including HVAC, refrigeration, and
Wire Stripping and Twisting Machine Market - Current Impact to Make Big Changes by 2030
Wire Stripping and Twisting Machine Market - Current Impact to Make Big Changes …
The global wire stripping and twisting machine market was valued at approximately $3.2 billion in 2023 and is projected to reach around $5.1 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.2% during the forecast period. Wire Stripping and Twisting Machine Market Overview The wire stripping and twisting machine market is experiencing significant growth, driven by the increasing automation across various sectors such as automotive,
Food Traceability Market - Current Impact to Make Big Changes by 2032
Food Traceability Market - Current Impact to Make Big Changes by 2032
The global food traceability market was valued at approximately $16.58 billion in 2023 and is projected to reach around $32.43 billion by 2032, growing at a compound annual growth rate (CAGR) of approximately 8% from 2024 to 2032. Food Traceability Market Overview The food traceability market is experiencing significant growth, driven by increasing consumer demand for transparency regarding the origins and safety of food products. Stringent governmental regulations worldwide are mandating

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug